
PURPOSE:Reducing nonemergent use of the emergency department (ED) is an important public health policy goal. Urgent care centers (UCCs) have recently increased in number and their impact on the characteristics and number of cases presenting to the ED is not yet fully understood. In this retrospective study, we attempt to characterize changes in upper limb trauma admissions to the ED in southern Israel after the opening of a nearby UCC. METHODS:Data were collected from the medical records at ED, Soroka University Medical Center. Patients with related upper limb traumas during the years 2011-2017 were included. The cases were divided into minor injuries, defined as those not requiring surgery or prolonged admission, and major injuries. We compared the number of cases presenting to the ED between two time periods, prior to and after the opening of the UCC (Jan. 2011 to Aug. 2014 vs. Sep. 2014 to Oct. 2017). Time series analysis and interrupted time series analysis were used to identify variations in incidence. We were unable to control for socioeconomic status, education, family status, and geographic location of trauma. RESULTS:A total of 103,75 upper limb trauma cases were included. Upper limb trauma admissions to the ED declined after the opening of a new UCC in the same geographic location. Prior to the UCC opening, the number of admissions to the ED increased by 12.1 per month on average, whereas after the UCC opened, there was a decline of 28.6 admissions to the ED every month, on average. This decline was found for all diagnoses except cases of open fractures which increased after the UCC opened. CONCLUSION:This study demonstrated a decline in the number of ED admissions for minor injuries, after the opening of a nearby UCC. This may suggest a benefit in resource reallocation and should be taken into consideration when formulating policy regarding patients' use of urgent care. Future research should focus on population trends of urgent care use to elucidate how to most efficiently direct patients on the use of the ED versus urgent care.
Tetanus is an acute infectious disease caused by Clostridium tetani, which enters the body through contaminated wounds, proliferates under anaerobic conditions, and produces neurotoxin. Patients with major trauma are at a markedly increased risk of tetanus owing to extensive tissue injury, heavy wound contamination, and trauma-associated impairment of immune function. Existing guidelines and consensus statements on tetanus prophylaxis largely address general open wounds and provide little specific guidance for patients with major trauma, particularly those undergoing emergency life-saving surgery through expedited care pathways or admitted to the intensive care unit. To standardize tetanus prophylaxis in the management of major trauma, the writing committee convened Chinese experts in emergency medicine, trauma surgery, critical care medicine, and immunology to develop this expert consensus based on the best available evidence and current clinical practice in China. The consensus covers the fundamental principles of tetanus prophylaxis in major trauma, damage-control debridement, assessment of immune status, active and passive immunization strategies, management of special injury types, prophylaxis in immunocompromised patients, response to mass-casualty incidents, and preventive strategies under resource-limited conditions, and it aims to provide practical guidance for tetanus prophylaxis during the clinical management of major trauma.
Purpose To investigate the current status of monoclonal anti-tetanus toxin antibody used for passive immunization in the prevention and management of post-traumatic tetanus in China, and to provide evidence for the selection of passive immunization agents for tetanus prophylaxis. Methods This retrospective, multicenter, real-world survey included patients who received a monoclonal anti-tetanus toxin antibody (siltartoxatug injection) for passive immunization following traumatic injury at participating hospitals across China between March 1 and August 20, 2025. Patients with incomplete registration data or at least 1 missing key variable were excluded. Demographic, clinical, wound-related, payment, and follow-up information was collected. According to the National Clinical Practice Guideline for Non-neonatal Tetanus Prevention and Treatment (2024 Edition), patients were classified into high- and low-risk tetanus exposure groups based on vaccination history, booster interval, wound characteristics, and immune status. Demographic, clinical, and wound-related characteristics were compared between the 2 groups. Statistical analyses were performed using IBM SPSS Statistics, version 26.0 (IBM Corp., Armonk, NY, USA). Categorical variables were presented as frequencies and percentages and compared using the chi-square test or Fisher's exact test, as appropriate. All statistical tests were two-sided, and a p value < 0.05 was considered statistically significant. Results A total of 423 hospitals from 28 provinces, autonomous regions, and municipalities participated in the survey and provided case data. Among 1474 patients who received monoclonal anti-tetanus toxin antibody for passive immunization following trauma, no tetanus cases were documented during the available observation period; however, follow-up duration was not standardized across centers, and the protective efficacy of the monoclonal antibody could not be definitively evaluated. Conclusion Standardized wound assessment and appropriate selection of passive immunization agents are crucial for tetanus prevention. Monoclonal anti-tetanus toxin antibody represents an effective and promising option for passive immunization against tetanus.
Tetanus is an acute, life-threatening disease caused by Clostridium tetani infection through breaches in the skin or mucous membranes, typically following traumatic injury. While human tetanus immunoglobulin (HTIG) is the preferred passive immunizing agent, documented cases of prophylaxis failure are rare despite theoretical possibilities. We present a case of generalized tetanus that developed 1 month after HTIG administration following trauma. This report highlights the potential failure of HTIG prophylaxis and analyzes its contributing factors to inform clinical practice.
PURPOSE:The introduction of intraoperative CT (iCT) has provided a new tool that may improve outcomes in the surgical management of maxillofacial fractures (MFFs). This systematic review and meta-analysis evaluated the clinical value of iCT in MFFs and identified the fracture types and circumstances in which it provides notable benefit. METHODS:PubMed, Scopus, and ClinicalTrials.gov were searched for clinical studies published or registered from January 2020 to November 2025. Random-effect models pooled the intraoperative CT revision rate and post-operative bilateral orbital volume difference across various fracture types. RESULTS:Eighteen studies (1165 patients; 12 cohorts, 1 case-control, and 5 case series) were included across zygomaticomaxillary complex, orbital, mandibular, and nasal fractures. Of these, 11 studies (n = 493) provided extractable quantitative data for the intraoperative revision meta-analysis, which yielded a pooled revision rate of 36% (I2 = 77%), with a fracture-type gradient (orbital 58% > other MFFs 49% > zygomaticomaxillary complex 26%; subgroup p < 0.001). High revision yield in orbital fractures suggests that iCT may enhance intraoperative verification of reduction and implant positioning during orbital reconstruction; however, evidence for post-operative volumetric symmetry remains limited and largely derived from observational studies. Mean iCT acquisition time was 4.2 to 18.9 min, and comparative data suggested no significant increase in total operative time. CONCLUSIONS:Overall, iCT appeared most valuable when 3-dimensional reduction accuracy or implant seating could not be confidently assessed before closure, especially in orbital reconstruction and anatomically constrained, symmetry-critical MFFs.